1Takikawa S, Ishii K, Aizaki H, et al . Cell fusion activity of hepatitis C virus envelope proteins, J Virol,2000,74:5066-5074
2Zhou YH, Takekoshi M, Maeda F, et al . Recombinant antibody Fab against the hypervariable region 1 of hepatitis C virus blocks the virus adsorption to susceptible cells in vitro. Antiviral Res, 2002,56:51-59
3Hunziker L, Ciurea A, Recher M,et al . Public versus personal serotypes of a viral quasispecies. Proc Natl Acad Sci US A,2003,100:6015-6020
4Zhou YH, Moriyama M, Esumi M. Multiple sequence-reactive antibodies induced by a single peptide immunization with hyperpervariable region 1 of hepatitis C virus. Virology,1999,256 : 360-370
5Mondelli MU, Cerino A, Lisa A, et al . Antibody responses to hepatitis C virus hypervariable region 1: evidence for cross-cross-reactivity and immune-mediated sequencevariation. Hepatology, 1999,30:537-545
6Li C, Candotti D, Allain JP, Production and characterization of monoclonal antibodies specific for a conserved epitope within hepatitis C virus hyprvariable region 1. J Virol 2001,75 : 12412-12420
7Chen M, Sallberg M, Sonnerborg A, et al . Limited humoral immunity in hepatitis C virus infection. Gastroenterology,1999,116 : 135-143
8Major ME, Mihalik K, Puig M, et al . Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol,2002,76:6586-6595
9Weiner AJ, Pallard X, Selby MJ, et al . Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity. J Virol, 2001,75:7142-7148
10Ichauspe G. Role of neutralizing antibodies and cellular immunity in hepatitis C virus infection. Transfus Clin Biol,2001,75:471-474
